Literature DB >> 9464208

Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases.

S E Swedo1, H L Leonard, M Garvey, B Mittleman, A J Allen, S Perlmutter, L Lougee, S Dow, J Zamkoff, B K Dubbert.   

Abstract

OBJECTIVE: The purpose of this study was to describe the clinical characteristics of a novel group of patients with obsessive-compulsive disorder (OCD) and tic disorders, designated as pediatric autoimmune neuropsychiatric disorders associated with streptococcal (group A beta-hemolytic streptococcal [GABHS]) infections (PANDAS).
METHOD: The authors conducted a systematic clinical evaluation of 50 children who met all of the following five working diagnostic criteria: presence of OCD and/or a tic disorder, prepubertal symptom onset, episodic course of symptom severity, association with GABHS infections, and association with neurological abnormalities.
RESULTS: The children's symptom onset was acute and dramatic, typically triggered by GABHS infections at a very early age (mean = 6.3 years, SD = 2.7, for tics; mean = 7.4 years, SD = 2.7, for OCD). The PANDAS clinical course was characterized by a relapsing-remitting symptom pattern with significant psychiatric comorbidity accompanying the exacerbations; emotional lability, separation anxiety, nighttime fears and bedtime rituals, cognitive deficits, oppositional behaviors, and motoric hyperactivity were particularly common. Symptom onset was triggered by GABHS infection for 22 (44%) of the children and by pharyngitis (no throat culture obtained) for 14 others (28%). Among the 50 children; there were 144 separate episodes of symptom exacerbation; 45 (31%) were associated with documented GABHS infection, 60 (42%) with symptoms of pharyngitis or upper respiratory infection (no throat culture obtained), and six (4%) with GABHS exposure.
CONCLUSIONS: The working diagnostic criteria appear to accurately characterize a homogeneous patient group in which symptom exacerbations are triggered by GABHS infections. The identification of such a subgroup will allow for testing of models of pathogenesis, as well as the development of novel treatment and prevention strategies.

Entities:  

Mesh:

Year:  1998        PMID: 9464208     DOI: 10.1176/ajp.155.2.264

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  245 in total

Review 1.  Personality in frontal lobe disorders.

Authors:  T W Chow
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

2.  Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis.

Authors:  A J Church; R C Dale; A J Lees; G Giovannoni; M M Robertson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

3.  Comorbidities of obsessive and compulsive symptoms in Huntington's disease.

Authors:  Karen E Anderson; Carissa R Gehl; Karen S Marder; Leigh J Beglinger; Jane S Paulsen
Journal:  J Nerv Ment Dis       Date:  2010-05       Impact factor: 2.254

4.  Neurological soft signs and disruptive behavior among children of opiate dependent parents.

Authors:  Jeffrey J Wilson; Daniel S Pine; Abba Cargan; Rise B Goldstein; Edward V Nunes; Myrna M Weissman
Journal:  Child Psychiatry Hum Dev       Date:  2003

Review 5.  A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder.

Authors:  Dan J Stein; Nastassja Koen; Naomi Fineberg; Leonardo F Fontenelle; Hisato Matsunaga; David Osser; H Blair Simpson
Journal:  Curr Psychiatry Rep       Date:  2012-06       Impact factor: 5.285

Review 6.  Post infectious CNS disorders: towards a unified approach.

Authors:  Marc Gotkine; Peter G E Kennedy; Israel Steiner
Journal:  J Neurol       Date:  2010-09-21       Impact factor: 4.849

7.  Identification and treatment of a pineal region tumor in an adolescent with prodromal psychotic symptoms.

Authors:  Vijay A Mittal; Katherine Karlsgodt; Jamie Zinberg; Tyrone D Cannon; Carrie E Bearden
Journal:  Am J Psychiatry       Date:  2010-09       Impact factor: 18.112

Review 8.  Tourette syndrome: gene expression as a tool to discover drug targets.

Authors:  Isaac H Liao; Frank R Sharp
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 9.  The management of tics.

Authors:  David Shprecher; Roger Kurlan
Journal:  Mov Disord       Date:  2009-01-15       Impact factor: 10.338

10.  How relevant are GFAP autoantibodies in autism and Tourette Syndrome?

Authors:  Nikki J Kirkman; Jane E Libbey; Thayne L Sweeten; Hilary H Coon; Judith N Miller; Edward K Stevenson; Janet E Lainhart; William M McMahon; Robert S Fujinami
Journal:  J Autism Dev Disord       Date:  2007-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.